タンパク質治療薬市場：タンパク質機能別、製品タイプ別-2025-2030年の世界予測

タンパク質治療薬市場は、2023年に786億6,000万米ドルと評価され、2024年には848億米ドルに達すると予測され、CAGR 7.90％で成長し、2030年には1,339億8,000万米ドルに達すると予測されています。

タンパク質治療薬には、モノクローナル抗体、インスリン、融合タンパク質など、主にがん、ホルモン障害、自己免疫疾患などのさまざまな疾患を対象とした、人工タンパク質に由来するさまざまな治療法が含まれます。これらの治療法は、その特異性、効力、従来の治療法に比べて軽減された副作用により、現代医療において重要な役割を果たしています。タンパク質治療薬の必要性は、慢性疾患の有病率の増加と個別化医療の必要性によって推進され、その応用範囲は腫瘍学、希少疾患、代謝性疾患に及んでいます。これらの治療法は、製薬会社、研究機関、ヘルスケアプロバイダーによって広く使用され、標的治療の選択肢を提供することを目指しています。市場の成長を後押ししているのは、組み換えDNA技術の進歩と、バイオ治療製品に対するFDA承認の増加です。バイオ医薬品企業は、臨床パイプラインの拡充とバイオ加工能力への投資に注力し、需要の増加に対応しています。潜在的な市場開拓機会は、バイオシミラー市場の拡大と、ヘルスケア・インフラが急速に発展している新興経済諸国における成長にあります。しかし、高い開発コスト、厳しい規制の枠組み、製造の複雑さといった課題は、市場の成長を妨げる可能性があります。さらに、知的財産の問題や低分子医薬品との競合がさらなる障壁となっています。医薬品開発におけるAIや機械学習、新規デリバリー・メカニズム、個別化医療の台頭といったイノベーションは、事業成長の大きな可能性を提供します。研究開発者は、スケーラビリティとコスト効率を向上させるために、連続処理やシングルユースシステムなどの革新的な製造技術に注目すべきです。市場力学はダイナミックであり、技術の進歩と研究開発の重視を特徴としています。企業がこの情勢を乗り切るには、専門知識とリソースを効果的に活用し、競争上の優位性と持続的な市場関連性を確保するための戦略的パートナーシップや協力関係が不可欠となります。

市場力学：急速に進化するタンパク質治療薬市場の主要市場インサイトを公開

タンパク質治療薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 新興市場におけるヘルスケア支出の増加
  • ヘルスケアサービス向上への政府の取り組み
  • 高齢者人口の増加と慢性疾患の増加
• 市場抑制要因
  • 生産コストが高く、タンパク質が大きいため組織への浸透効率が低いなどのタンパク質治療薬の制限事項
  • 腸内で変性するため、経口薬としての入手性に懸念
• 市場機会
  • 二重特異性モノクローナル抗体の可能性
  • 新興諸国におけるアンメットニーズ
• 市場の課題
  • 製造・治療コストの高さ
  • バイオシミラーとの競合

ポーターの5つの力タンパク質治療薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：タンパク質治療薬市場における外部からの影響の把握

外部マクロ環境要因は、タンパク質治療薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析タンパク質治療薬市場における競合情勢の把握

タンパク質治療薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスタンパク質治療薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、タンパク質治療薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨タンパク質治療薬市場における成功への道筋を描く

タンパク質治療薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 新興市場におけるヘルスケア費の増加
    • ヘルスケアサービスの改善に向けた政府の取り組み
    • 高齢者人口の増加と慢性疾患の増加
  • 抑制要因
    • タンパク質治療薬には、生産コストが高く、タンパク質が大きく組織への浸透効率が低いなどの制限があります。
    • 腸内での変性により経口薬としての利用可能性が懸念される
  • 機会
    • 二重特異性モノクローナル抗体の可能性
    • 新興諸国における満たされていない医療ニーズ
  • 課題
    • 生産と治療のコストが高い
    • バイオシミラーとの競合
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 タンパク質治療薬市場タンパク質の機能別

• 酵素と調節
• タンパク質診断
• ワクチン

第7章 タンパク質治療薬市場：製品タイプ別

• 血液凝固因子
• エリスロポエチン
• 卵胞刺激ホルモン
• G-CSF
• インスリン
• インターフェロン
• モノクローナル抗体

第8章 南北アメリカのタンパク質治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のタンパク質治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのタンパク質治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Ambrx, Inc.
• Amgen,Inc.
• Aravive, Inc.
• AstraZeneca Plc
• Atomwise Inc.
• Autolus Therapeutics Plc
• Baxter International, Inc.
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Genentech, Inc.
• LabGenius Limited
• LGC Group
• Merck & Co. Inc.
• Morphic Therapeutic, Inc.
• Omeros Corporation
• Pfizer, Inc.
• Sanofi S.A.

LIST OF FIGURES

• FIGURE 1. PROTEIN THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. PROTEIN THERAPEUTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. PROTEIN THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. PROTEIN THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PROTEIN THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PROTEIN THERAPEUTICS MARKET DYNAMICS
• TABLE 7. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC & REGULATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 27. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 37. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 39. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 41. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 43. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 45. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 47. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 49. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 51. SINGAPORE PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 53. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 55. TAIWAN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 57. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 59. VIETNAM PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 64. DENMARK PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 66. EGYPT PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 68. FINLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 70. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 72. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 74. ISRAEL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 76. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 78. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 80. NIGERIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 82. NORWAY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. POLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 84. POLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 86. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 88. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 90. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 94. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 96. SWEDEN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 98. SWITZERLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 100. TURKEY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 102. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
• TABLE 104. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. PROTEIN THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 106. PROTEIN THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Protein Therapeutics Market was valued at USD 78.66 billion in 2023, expected to reach USD 84.80 billion in 2024, and is projected to grow at a CAGR of 7.90%, to USD 133.98 billion by 2030.

Protein therapeutics encompass a spectrum of treatment modalities derived from engineered proteins, including monoclonal antibodies, insulin, and fusion proteins, primarily targeting a range of diseases such as cancer, hormonal disorders, and autoimmune diseases. These therapies play a crucial role in modern medicine due to their specificity, potency, and reduced side effects compared to traditional treatments. The necessity for protein therapeutics is driven by the increasing prevalence of chronic diseases and the need for personalized medicine, with applications spanning oncology, rare diseases, and metabolic disorders. These therapies are extensively used by pharmaceutical companies, research institutions, and healthcare providers aiming to deliver targeted treatment options. Market growth is propelled by advancements in recombinant DNA technology and an increasing number of FDA approvals for biotherapeutic products. Biopharmaceutical companies are focusing on expanding their clinical pipelines and investing in bioprocessing capabilities to meet the increasing demand. Potential opportunities lie in the expanding biosimilars market and growth in emerging economies where healthcare infrastructure is rapidly developing. However, challenges such as high development costs, stringent regulatory frameworks, and the complexity involved in manufacturing can hinder market growth. Moreover, intellectual property issues and competition from small molecule drugs present additional barriers. Innovations such as AI and machine learning in drug development, novel delivery mechanisms, and the rise of personalized medicine offer significant potential for business growth. Researchers and developers should focus on innovative manufacturing techniques like continuous processing and single-use systems to improve scalability and cost-efficiency. The protein therapeutics market is dynamic, characterized by technological advancements and a strong emphasis on R&D. As companies navigate this landscape, strategic partnerships and collaborations will be essential to leverage expertise and resources effectively, ensuring competitive advantage and sustained market relevance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Protein Therapeutics Market

The Protein Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing healthcare expenditure in the emerging markets
  • Government initiatives to improve the healthcare services
  • Growing geriatric population & rising predominance of chronic diseases
• Market Restraints
  • Limitations to protein therapeutics such as high production costs and large proteins with low efficiency to penetrate in tissue
  • Availability concerns as oral drugs due to denaturation in the gut
• Market Opportunities
  • Potential for bispecific monoclonal antibodies
  • Unmet medical needs in developing countries
• Market Challenges
  • High cost of production and treatment
  • Competition from biosimilars

Porter's Five Forces: A Strategic Tool for Navigating the Protein Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Protein Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Protein Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Protein Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Protein Therapeutics Market

A detailed market share analysis in the Protein Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Protein Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Protein Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Protein Therapeutics Market

A strategic analysis of the Protein Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Protein Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Ambrx, Inc., Amgen,Inc., Aravive, Inc., AstraZeneca Plc, Atomwise Inc., Autolus Therapeutics Plc, Baxter International, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Genentech, Inc., LabGenius Limited, LGC Group, Merck & Co. Inc., Morphic Therapeutic, Inc., Omeros Corporation, Pfizer, Inc., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Protein Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Protein Function, market is studied across Enzymatic & Regulatory, Protein Diagnostics, and Vaccines.
• Based on Product Type, market is studied across Blood Clotting Factor, Erythropoietin, Follicle Stimulating Hormone, G-CSF, Insulin, Interferons, and Monoclonal Antibodies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing healthcare expenditure in the emerging markets
    • 5.1.1.2. Government initiatives to improve the healthcare services
    • 5.1.1.3. Growing geriatric population & rising predominance of chronic diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Limitations to protein therapeutics such as high production costs and large proteins with low efficiency to penetrate in tissue
    • 5.1.2.2. Availability concerns as oral drugs due to denaturation in the gut
  • 5.1.3. Opportunities
    • 5.1.3.1. Potential for bispecific monoclonal antibodies
    • 5.1.3.2. Unmet medical needs in developing countries
  • 5.1.4. Challenges
    • 5.1.4.1. High cost of production and treatment
    • 5.1.4.2. Competition from biosimilars
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Protein Therapeutics Market, by Protein Function

• 6.1. Introduction
• 6.2. Enzymatic & Regulatory
• 6.3. Protein Diagnostics
• 6.4. Vaccines

7. Protein Therapeutics Market, by Product Type

• 7.1. Introduction
• 7.2. Blood Clotting Factor
• 7.3. Erythropoietin
• 7.4. Follicle Stimulating Hormone
• 7.5. G-CSF
• 7.6. Insulin
• 7.7. Interferons
• 7.8. Monoclonal Antibodies

8. Americas Protein Therapeutics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Protein Therapeutics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Protein Therapeutics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Ambrx, Inc.
• 2. Amgen,Inc.
• 3. Aravive, Inc.
• 4. AstraZeneca Plc
• 5. Atomwise Inc.
• 6. Autolus Therapeutics Plc
• 7. Baxter International, Inc.
• 8. Eli Lilly and Company
• 9. F. Hoffmann-La Roche AG
• 10. Genentech, Inc.
• 11. LabGenius Limited
• 12. LGC Group
• 13. Merck & Co. Inc.
• 14. Morphic Therapeutic, Inc.
• 15. Omeros Corporation
• 16. Pfizer, Inc.
• 17. Sanofi S.A.